Biodexa Pharmaceuticals PLC ADR (BDRX)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
0. 46
+0.03
+5.8005%
$
343.36K Market Cap
- P/E Ratio
- Div Yield
619,300 Volume
- Eps
$ 0.43
Previous Close 
Want to track BDRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Upcoming BDRX split of 1:8 in 9 days (26 Oct 2026)
Biodexa Pharmaceuticals stock more than doubled on Tuesday: explore why
Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) opened more than 100% up on Tuesday after reporting encouraging Phase 2 data for eRapa.
Invezz | 2 years ago
Biodexa Pharmaceuticals stock more than doubled on Tuesday: explore why
Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) opened more than 100% up on Tuesday after reporting encouraging Phase 2 data for eRapa.
Invezz | 2 years ago
Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 78% Today?
Biodexa Pharmaceuticals (NASDAQ: BDRX ) stock is rocketing higher on Tuesday alongside heavy pre-market trading of the clinical-stage biopharmaceutical company's shares. This has more than 15.8 million shares of BDRX stock changing hands as of this writing.
Investorplace | 2 years ago
2026 © Marketlog. All Rights Reserved.
